Journalartikel
Autorenliste: Dietrich, Sascha; Huellein, Jennifer; Hundemer, Michael; Lehners, Nicola; Jethwa, Alexander; Capper, David; Acker, Till; Garvalov, Boyan K.; Andrulis, Mindaugas; Blume, Carolin; Schulte, Christoph; Mandel, Thomas; Meissner, Julia; Froehling, Stefan; von Kalle, Christof; Glimm, Hanno; Ho, Anthony D.; Zenz, Thorsten
Jahr der Veröffentlichung: 2013
Seiten: E300-E303
Zeitschrift: Journal of Clinical Oncology
Bandnummer: 31
Heftnummer: 19
ISSN: 0732-183X
eISSN: 1527-7755
Open Access Status: Bronze
DOI Link: https://doi.org/10.1200/JCO.2012.45.9495
Verlag: American Society of Clinical Oncology
Zitierstile
Harvard-Zitierstil: Dietrich, S., Huellein, J., Hundemer, M., Lehners, N., Jethwa, A., Capper, D., et al. (2013) Continued Response Off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia, Journal of Clinical Oncology, 31(19), pp. E300-E303. https://doi.org/10.1200/JCO.2012.45.9495
APA-Zitierstil: Dietrich, S., Huellein, J., Hundemer, M., Lehners, N., Jethwa, A., Capper, D., Acker, T., Garvalov, B., Andrulis, M., Blume, C., Schulte, C., Mandel, T., Meissner, J., Froehling, S., von Kalle, C., Glimm, H., Ho, A., & Zenz, T. (2013). Continued Response Off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia. Journal of Clinical Oncology. 31(19), E300-E303. https://doi.org/10.1200/JCO.2012.45.9495
Schlagwörter
CLADRIBINE TREATMENT; Melanoma; PENTOSTATIN; REMISSIONS; TERM-FOLLOW-UP; V600E MUTATION
